About Margarita Chavez
Form D filings for SNC Therapeutics in 2023 list Margarita Chavez as director.
Margarita Chavez first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Margarita Chavez in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Margarita Chavez works with at each company, as listed on that company's latest Form D.
SNC Therapeutics, Inc. · Form D, Mar 8, 2023
ES
Evan Scott
Chief Executive Officer and director
JH
Jeffrey Hubbell
Executive officer